IRVINE, Calif., Oct. 18, 2011 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its third quarter 2011 financial results, which will take place on Thursday, October 27, 2011 after the close of the market.
